November 28, 2023

New contamination-detection test to improve T-cell therapy

James Strutt

Senior Postdoctoral Associate

Stacy L. Springs

Executive Director MIT Biomanufacturing Program (BioMAN) and Center for Biomedical Innovation (CBI)

Sin Wei Xiang

Research Scientist

Faye Cheung

Research Scientist

Denise Teo

Research Engineer

Rohan Williams

Head, Integrative Analysis Unit Singapore Centre on Environmental Life Science Engineering (SCELSE), NUS

Meenubharathi Natarajan

Senior Research Engineer

Method to improve sterility assurance in biopharmaceutical manufacturing will lead to better patient outcomes.

A novel method that can identify contaminants in T cell cultures within 24 hours has been developed by researchers from Critical Analytics for Manufacturing Personalized-Medicine (CAMP) Interdisciplinary Research Group (IRG) at Singapore-MIT Alliance for Research and Technology (SMART), MIT’s research enterprise in Singapore, in collaboration with Singapore Centre for Environmental Life Sciences Engineering (SCELSE) and Massachusetts Institute of Technology (MIT).

‍

https://www.drugtargetreview.com/news/112861/new-contamination-detection-test-to-improve-t-cell-therapy/

‍

https://journals.asm.org/doi/epub/10.1128/spectrum.01350-23

‍

‍

New contamination-detection test to improve T-cell therapy

Latest News